Faculty and Staff
|
Chia-Ron Yang
Field of study：Fibrosis, Neurodegenerative disease/anti-cancer/anti-inflammaory disease drug development, mechanism study Signal transduction study
Telephone：(02)3366-8758
E-mail：cryang@ntu.edu.tw
My job：Professor / Director, Drug Research Center / Director, Convener of Office of the Bachelor’s Degree Program in Biotechnology and Pharmaceutical Sciences
Personal website：https://scholars.lib.ntu.edu.tw/cris/rp/rp06466
| Education | : | Ph.D. Pharmacology NTU |
| Experience | : | Assistant Professor, Associate Professor, Professor, School of Pharmacy, National Taiwan University |
| Research Areas | : | Fibrosis, Neurodegenerative disease/anti-cancer/anti-inflammaory disease drug development, mechanism study Signal transduction study |
| Lab Focus | : | 1. Fibrotic disease, Neurodegenerative disease and anti-cancer drug discovery and mechanism study. 2. Biological activity evaluation and signal transduction study. |
| Research Subjects | : | Fibrotic disease, Neurodegenerative disease and anti-cancer drug discovery and mechanism study |
| Lab Requirements | : | *Independence *Enjoy your Experiments |
Anticancer Study of a Novel Pan-HDAC Inhibitor MPT0G236 in Colorectal Cancer Cells
(2023-08-09) Tsai, Feng-Lung ; Huang, Han-Li ; Lai, Mei-Jung ; Liou, Jing-Ping ; Pan, Shiow-Lin ; CHIA-RON YANG
The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo
(2023-06) Ho, Tai-Yuan ; Sung, Ting-Yi ; Pan, Shiow-Lin ; Huang, Wei-Jan ; Hsu, Kai-Cheng ; Hsu, Jui-Yi ; Lin, Tony Eight ; Hsu, Chia-Ming ; CHIA-RON YANG
Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors
(2023-03) Hsu, Jui-Yi ; Hsu, Kai-Cheng ; Sun, Ching ; Chou, Ching-Hsuan ; Lin, Tony Eight ; Sung, Tzu-Ying ; Tseng, Hui-Ju ; Yen, Shih-Chung ; CHIA-RON YANG ; Huang, Wei-Jan
Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK/NF-κB and glutamatergic pathways
(2022-10-15) Zhang, Nai-You ; Wang, Ting-Hsuan ; Chou, Ching-Hsuan ; Wu, Kuo-Chen ; CHIA-RON YANG ; FAN-LU KUNG ; CHUN-JUNG LIN
Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment
(2022) Lin T.E. ; CHIA-RON YANG ; Chou C.-H. ; Hsu J.-Y. ; Chao M.-W. ; Sung T.-Y. ; Hsieh J.-H. ; Huang W.-J. ; Hsu K.-C.
(2023-08-09) Tsai, Feng-Lung ; Huang, Han-Li ; Lai, Mei-Jung ; Liou, Jing-Ping ; Pan, Shiow-Lin ; CHIA-RON YANG
The study of a novel CDK8 inhibitor E966-0530-45418 that inhibits prostate cancer metastasis in vitro and in vivo
(2023-06) Ho, Tai-Yuan ; Sung, Ting-Yi ; Pan, Shiow-Lin ; Huang, Wei-Jan ; Hsu, Kai-Cheng ; Hsu, Jui-Yi ; Lin, Tony Eight ; Hsu, Chia-Ming ; CHIA-RON YANG
Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors
(2023-03) Hsu, Jui-Yi ; Hsu, Kai-Cheng ; Sun, Ching ; Chou, Ching-Hsuan ; Lin, Tony Eight ; Sung, Tzu-Ying ; Tseng, Hui-Ju ; Yen, Shih-Chung ; CHIA-RON YANG ; Huang, Wei-Jan
Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK/NF-κB and glutamatergic pathways
(2022-10-15) Zhang, Nai-You ; Wang, Ting-Hsuan ; Chou, Ching-Hsuan ; Wu, Kuo-Chen ; CHIA-RON YANG ; FAN-LU KUNG ; CHUN-JUNG LIN
Discovery of a novel cyclin-dependent kinase 8 inhibitor with an oxindole core for anti-inflammatory treatment
(2022) Lin T.E. ; CHIA-RON YANG ; Chou C.-H. ; Hsu J.-Y. ; Chao M.-W. ; Sung T.-Y. ; Hsieh J.-H. ; Huang W.-J. ; Hsu K.-C.
Novel Cyclin-Dependent Kinase 8 Inhibitor Lead Compound Development and Application in Pulmonary Fibrosis
(2023-08-01～) CHIA-RON YANG
Novel Cyclin-Dependent Kinase 8 Inhibitor Lead Compound Development and Application in Pulmonary Fibrosis
(2022-08-01～) CHIA-RON YANG
Characterization of the Mechanisms of Histone Deacetylase 6 in Glioblastoma Multiforme Growth and the Specific Histone Deacetylase 6 Inhibitor Lead Compound Development
(2022-08-01～) CHIA-RON YANG
Characterization of the Mechanisms of Histone Deacetylase 6 in Glioblastoma Multiforme Growth and the Specific Histone Deacetylase 6 Inhibitor Lead Compound Development
(2021-08-01～) CHIA-RON YANG
Characterization of the Mechanisms of Histone Deacetylase 6 in Glioblastoma Multiforme Growth and the Specific Histone Deacetylase 6 Inhibitor Lead Compound Development
(2020-08-01～) CHIA-RON YANG
(2023-08-01～) CHIA-RON YANG
Novel Cyclin-Dependent Kinase 8 Inhibitor Lead Compound Development and Application in Pulmonary Fibrosis
(2022-08-01～) CHIA-RON YANG
Characterization of the Mechanisms of Histone Deacetylase 6 in Glioblastoma Multiforme Growth and the Specific Histone Deacetylase 6 Inhibitor Lead Compound Development
(2022-08-01～) CHIA-RON YANG
Characterization of the Mechanisms of Histone Deacetylase 6 in Glioblastoma Multiforme Growth and the Specific Histone Deacetylase 6 Inhibitor Lead Compound Development
(2021-08-01～) CHIA-RON YANG
Characterization of the Mechanisms of Histone Deacetylase 6 in Glioblastoma Multiforme Growth and the Specific Histone Deacetylase 6 Inhibitor Lead Compound Development
(2020-08-01～) CHIA-RON YANG